NDC 83831-183 – Bendamustine Hydrochloride
Bendamustine Hydrochloride 100 mg/4mL · Injection · Intravenous
Product NDC83831-183
Product details
- Brand name
- Bendamustine Hydrochloride
- Generic name
- Bendamustine hydrochloride
- Labeler
- Avyxa Pharma, LLC
- Dosage form
- Injection
- Route
- Intravenous
- Marketing category
- NDA · NDA219014
- Marketed since
- May 29, 2026
- Listing expires
- December 31, 2027
- Pharmacologic class
- Alkylating Drug
Active ingredients
- Bendamustine Hydrochloride 100 mg/4mL
Uses, dosage, side effects and warnings for Bendamustine Hydrochloride →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 83831-183-04 | 1 VIAL in 1 CARTON (83831-183-04) / 4 mL in 1 VIAL | May 29, 2026 |
Other Bendamustine Hydrochloride products
- 10019-079 Bendamustine Hydrochloride 100 mg/1 · Injection · Baxter Healthcare Corporation
- 16729-250 Bendamustine Hydrochloride 25 mg/5mL · Injection, Powder, Lyophilized, For Solution · Accord Healthcare, Inc.
- 16729-251 Bendamustine Hydrochloride 100 mg/20mL · Injection, Powder, Lyophilized, For Solution · Accord Healthcare, Inc.
- 60505-6228 Bendamustine Hydrochloride 25 mg/mL · Injection, Solution · Apotex Corp
- 68001-572 Bendamustine Hydrochloride 100 mg/20mL · Injection, Powder, Lyophilized, For Solution · BluePoint Laboratories
- 55150-391 Bendamustine Hydrochloride 25 mg/5mL · Injection, Powder, Lyophilized, For Solution · Eugia US LLC
- 55150-392 Bendamustine Hydrochloride 100 mg/20mL · Injection, Powder, Lyophilized, For Solution · Eugia US LLC